Trials / Completed
CompletedNCT02204163
Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
A Phase III, Multi-center, Randomized, Comparative, Parallel, Open Study to Assess the Efficacy and Safety After Treatment of Eutropin® Inj. Compared to Genotropin® in Infants/Toddlers With Prader-Willi Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Evaluate the efficacy and safety after treatment of Eutropin® inj. compared to Genotropin® in infants/toddlers with Prader-Willi syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eutropin | |
| DRUG | Genotropin |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2014-07-30
- Last updated
- 2019-06-27
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02204163. Inclusion in this directory is not an endorsement.